Exogene is a VC-backed biotechnology startup using AI to unlock the discovery of novel therapies for cancer treatment. Utilising generative AI, we are uncovering new T-cell receptors (TCRs) with the potential to precisely target and eliminate cancer cells in the body.
Exogene is a VC-backed biotechnology startup using AI to unlock the discovery of novel therapies for cancer treatment. Utilising generative AI, we are uncovering new T-cell receptors (TCRs) with the potential to precisely target and eliminate cancer cells in the body.